The landscape of diabetes care is changing with the emergence of skin-applied GLP-1 therapy. These novel patches offer a possibly more comfortable alternative to shots for individuals living with diabetes mellitus type 2 . These patches deliver a GLP-1 agonist directly through the epidermis, bypassing the requirement for daily injections and pos… Read More